Walleye Capital’s Kodiak Sciences KOD Stock Holding History

Walleye Capital’s Portfolio KOD Stock Details KOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,100	Closed	-$156K	–	4971
2026 Q1	$156K	Buy	+4,100	New	+$106K	﹤0.01%	3470
2023 Q4	–	Sell	-700	Closed	-$1.26K	–	5238
2023 Q3	$1.26K	Buy	+700	New	+$2.47K	﹤0.01%	4745

Other funds holding KOD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Jupiter Topco New York $245B AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Walleye Capital's KOD Position: Q2 2026 in Review

Walleye Capital sold out of Kodiak Sciences (KOD) in Q2 2026, closing a stake of 23,572 shares — an estimated $899K sold.

Walleye Capital first reported a position in KOD in Q4 2021 and held it in 7 quarters. The position peaked at $2.75M in Q1 2022. 200 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

Walleye Capital reported no remaining Kodiak Sciences position as of Q2 2026 after selling out during the quarter.
Walleye Capital sold 23,572 Kodiak Sciences shares in Q2 2026, an estimated $899K.
Walleye Capital first reported a position in Kodiak Sciences in Q4 2021 and held it in 7 quarters.
Walleye Capital's Kodiak Sciences position peaked at $2.75M in Q1 2022.
200 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.